Finance

Lists
500087:BOM
Cipla Ltd
₹1,393.00
-1.21%
(-17.00) 1D
Nov 13, 3:59:41 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 500087...
Open
₹1,405.85
High
₹1,418.10
Low
₹1,393.00
Mkt. cap
1.13T
Avg. vol.
59.94K
Volume
429.91K
Dividend
0.93%
Quarterly dividend
₹3.25
Ex-dividend date
Jun 5, 2026
P/E ratio
38.87
52-wk high
₹1,539.25
52-wk low
₹1,165.55
EPS
₹35.83
Shares outstanding
805.67M
No. of employees
31K
Open
₹1,405.85
High
₹1,418.10
Low
₹1,393.00
Mkt. cap
1.13T
Avg. vol.
59.94K
Volume
429.91K
Dividend
0.93%
Quarterly dividend
₹3.25
Ex-dividend date
Jun 5, 2026
P/E ratio
38.87
52-wk high
₹1,539.25
52-wk low
₹1,165.55
EPS
₹35.83
Shares outstanding
805.67M
No. of employees
31K
News stories
From web sources and news partners
Profile
Cipla Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. Cipla primarily focuses on developing medication to treat respiratory disease, cardiovascular disease, arthritis, diabetes, depression, paediatric and various other medical conditions. Cipla has 47 manufacturing locations across the world and sells its products in 86 countries. It is the third-largest drug producer in India. Wikipedia
About Cipla Ltd
CEOUmang Vohra
Employees31.4K
Founded1935
HeadquartersMumbai, Maharashtra, India
SectorHealth Care
IndustryPharmaceutical industry
Websitecipla.com
Last report
Oct 27, 2026
Fiscal period
Q2 2027
₹10.85 / ₹11.83
-8.28%miss
Revenue / Est. (INR)
73.68B / 75.88B
-2.90%miss
Fiscal Q2 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
69.63B
65.80B
70.77B
73.68B
Cost of goods sold
26.32B
25.10B
26.67B
26.34B
Cost of revenue
26.32B
25.10B
26.67B
26.34B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
13.25B
28.23B
14.97B
14.75B
Operating expense
33.54B
33.30B
35.22B
36.91B
Total operating expenses
59.86B
58.39B
61.89B
63.25B
Operating income
9.77B
7.41B
8.88B
10.43B
Other non operating income
2.06B
-5.35B
2.11B
1.51B
EBT including unusual items
8.93B
6.99B
10.80B
11.72B
EBT excluding unusual items
11.69B
4.51B
10.80B
11.72B
Income tax expense
2.19B
1.57B
2.95B
3.21B
Effective tax rate
24.48%
22.44%
27.29%
27.37%
Other operating expenses
17.51B
2.51B
17.20B
18.72B
Net income
6.76B
5.55B
7.89B
8.78B
Net profit margin
9.71%
8.43%
11.15%
11.91%
Earnings per share
10.94
6.86
9.76
10.85
Interest and investment income
-
2.07B
-
-
Interest expense
-140.30M
-69.70M
-170.30M
-167.40M
Net interest expenses
-140.30M
2.00B
-170.30M
-167.40M
Depreciation and amortization charges
2.78B
2.56B
3.04B
3.45B
EBITDA
12.00B
9.82B
11.29B
13.67B
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google apps